Approvals/TGA/SKYRIZI risankizumab 600 mg/10 mL concentrate solution for intravenous infusion vial

Approved

STANDARD

SKYRIZI risankizumab 600 mg/10 mL concentrate solution for intravenous infusion vial

AbbVie Pty Ltd🇦🇺 Therapeutic Goods Administration

Approval Id: 6534b9944dd215bf
Product Name: SKYRIZI risankizumab 600 mg/10 mL concentrate solution for intravenous infusion vial
Artg Id: 375984
Artg Name: SKYRIZI risankizumab 600 mg/10 mL concentrate solution for intravenous infusion vial
Sponsor: AbbVie Pty Ltd
Company Detail Path: /organization/abbvie-pty-ltd
Artg Date: 2022-10-05
Registration Type: Medicine
Therapeutic Good Type: Medicine
Licence Status: A
Licence Category: RE
Consumer Medicine Info: https://medical-cdn.nocode.com/drug_tga/51adddacc24428a126b6c1024b93eaa8.pdf
Product Information: https://medical-cdn.nocode.com/drug_tga/251db23c825ebf280e39fb3161d6b9c4.pdf

Approved

Agency

TGA

Country

🇦🇺

Approval Date

May 30, 2025

Approval ID

6534b9944dd215bf

Type

Standard